Moderna, Inc. Stock price

Equities

MRNA

US60770K1079

Biotechnology & Medical Research

Delayed Nasdaq 04:00:00 2023-09-29 pm EDT Intraday chart for Moderna, Inc. 5-day change 1st Jan Change
103.29 USD +3.01% +3.30% -42.50%
Sales 2023 * 7,189 M Sales 2024 * 6,217 M Capitalization 39 311 M
Net income 2023 * -1,508 M Net income 2024 * -1,901 M EV / Sales 2023 *
4,48x
Net cash position 2023 * 7,073 M Net cash position 2024 * 5,850 M EV / Sales 2024 *
5,38x
P/E ratio 2023 *
-26,3x
P/E ratio 2024 *
-20,9x
Employees -
Yield 2023 *
-
Yield 2024 *
-
Free-Float90.33%
More Fundamentals * Assessed data
Dynamic Chart
1 day+3.01%
1 week+3.30%
Current month-8.65%
1 month-10.95%
3 months-15.41%
6 months-30.58%
Current year-42.50%
More quotes
1 week
97.11
Extreme 97.11
104.74
1 month
97.11
Extreme 97.11
116.60
Current year
95.02
Extreme 95.02
207.51
1 year
95.02
Extreme 95.02
217.25
3 years
65.49
Extreme 65.4899
497.49
5 years
11.54
Extreme 11.54
497.49
10 years
11.54
Extreme 11.54
497.49
More quotes
Date Price Change Volume
23-09-29 103.29 +3.01% 4,202,908
23-09-28 100.27 +0.83% 2,034,489
23-09-27 99.44 +1.35% 2,367,422
23-09-26 98.12 -0.05% 2,888,397
23-09-25 98.17 -1.82% 2,908,970

Delayed Quote Nasdaq, September 29, 2023 at 04:00 pm EDT

More quotes
Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for cancer, infectious, autoimmune and cardiovascular diseases. Net sales break down by type of revenue as follows: - revenue from product sales (95.7%) ; - revenues from grants (4%); - revenues from collaboration agreements (0.3%). At the end of 2021, the group possessed a portfolio of 15 products in clinical development, of which 3 in phase III, 8 in phase II and 4 in phase I, and 12 products in preclinical development. Net sales are distributed geographically as follows: the United States (33.4%), Europe (37.1%) and other (29.5%).
More about the company
Trading Rating :
Investor Rating :
ESG Refinitiv :
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
103.29USD
Average target price
182.39USD
Spread / Average Target
+76.58%
Consensus
  1. Markets
  2. Equities
  3. Stock Moderna, Inc. - Nasdaq
Discover our Free Content to Help You Better Understand the Stock Market.
100% Free Registration
fermer